Some of the most active companies traded Friday on the Toronto Stock Exchange:
Toronto Stock Exchange (15,215.26, down 115.48 points):
Mercator Minerals Ltd. (TSX:ML). Miner. Unchanged at 5.5 cents on 7.2 million shares.
Bombardier Inc. (TSX:BBD.B). Aerospace. Up seven cents, or 1.88 per cent, to $3.80 on 5.4 million shares.
Canadian Natural Resources Ltd. (TSX:CNQ). Oil and gas. Down $1.58, or 3.32 per cent, to $45.95 on 4.7 million shares.
Yamana Gold Inc. (TSX:YRI). Miner. Up 17 cents, or 1.83 per cent, to $9.47 on 4.5 million shares.
Eldorado Gold Corp. (TSX:ELD). Miner. Up 56 cents, or 6.92 per cent, to $8.65 on 4.1 million shares.
Suncor Energy Inc. (TSX:SU). Oil and gas. Down $1.34, or 2.99 per cent, to $43.43 on 4.05 million shares.
Companies reporting major news:
Bell Aliant Inc. (TSX:BA). Communication Services. Up four cents, or 0.13 per cent, to $30.94 on 1.9 million shares. The regional telecom company reported a second-quarter profit of $72 million, or 32 cents per share, compared with $66 million, or 29 cents per share, a year ago. Revenues were down at $683 million from $692 million year-over-year. BCE Inc., which already owns 44 per cent of Bell Aliant, recently announced it’s seeking to take full ownership of the company through a $3.95-billion deal.
Enbridge Inc. (TSX:ENB). Oil and gas. Up 45 cents, or 0.84 per cent, to $53.90 on 2.2 million shares. The Canadian gas distributor reported adjusted earnings rose to $328 million or 40 cents per share from $306 million, or 38 cents, a year earlier — a penny better than expected.
Fairfax Financial Holdings Ltd. (TSX:FFH). Up $4.65, or 0.91 per cent, to $518 on 92,905 shares. Billionaire investor Prem Watsa, who is chairman and chief executive of the investment firm, and the company’s president Paul Rivett are facing an investigation by Quebec’s securities regulator over possible insider trading or tipping. The company reported that second-quarter net earnings grew to US$363.7 million from a loss of $157.8 million a year earlier when it booked losses in its bond portfolio. The profit was worth $16.15 per diluted share compared with $8.55 per share a year ago. Revenue grew to $2.41 billion from $1.36 billion.
Valeant Pharmaceuticals International Inc. (TSX:VRX). Health. Up $1.30, or 1.02 per cent, to $129.22 on 874,863 shares. Botox maker Allergan, which is defending itself from a hostile takeover by Valeant Pharmaceuticals, is accusing the Montreal-area company and its partner Pershing Square Capital Management of fraud and insider trading. The suit filed Friday in California claims that New York-based Pershing Square purchased more than $3.2 billion of Allergan shares between February and April while quietly helping Valeant to mount a US$50-billion acquisition bid.